Skip to main content
. 2019 Feb 13;2019(2):CD013143. doi: 10.1002/14651858.CD013143.pub2

2. Participants in included study.

Study name Intervention(s) and comparator(s) Screened/eligible (N) Randomised (N) Analysed (N): efficacya Analysed (N): safetyb Finishing study (N (%))
Gilling 2018 Aquablation 275/184 117 114 116 115 (98.2)
TURP monopolar (36 (55.4%), bipolar 29 (44.6%)) 67 60 65 62 (92.5)
Total 184 174 181 177
TURP: transurethral resection of prostate

aThe number of participants analysed for urologic symptom scores.
 bThe number of participants with adverse events.